Decentralized Trial Technology Resources
-
Safety Monitoring: What Does ePRO Have To Do With It?
1/10/2022
In the available blog post, learn about the importance of safety monitoring in clinical trials.
-
How eCOA Improves Patient Experience
8/10/2022
Explore how to ensure that clinical trials are truly patient-centered, and why it is critical to do so.
-
The Transformative Impact Of EDC Systems In 2025
5/6/2025
The shift towards decentralized and hybrid trials underscores the significance of EDC in expanding geographic reach, fostering diversity in participant populations, and reduce participant burden.
-
eSource Enables Speed, Flexibility, And Higher-Quality Data
7/22/2022
A truly integrated eSource Solution, including DDC, eCOA, and eConsent, facilitates remote or decentralized clinical trials by ingesting data from multiple sources and consolidating it into a single data set.
-
The Definitive Guide To Decentralized Clinical Trials
6/8/2023
See how the clinical trial landscape has changed, and why many sponsors are choosing to make digital and decentralized trials a key part of their future.
-
Deconstructing Central Rating In Clinical Trials
1/27/2025
Analyze several commonly held misconceptions about Central Rating and its ability to ensure data validity and study success in this
-
Increase Participant Diversity With eClinical Tools
4/14/2023
The right technology and community partnerships can help sponsors meet FDA diversity requirements without additional expenditures, build relationships with minorities, and prepare for future trials.
-
Collecting Trial Data From Patients In Remote Areas
2/28/2024
Learn how mobile technology can promote trial inclusivity and diversity, and its potential to revolutionize clinical studies, making them more accessible and representative of the population.
-
The Language Of eCOAs
6/3/2022
In this article, learn more about COAs, and their electronic counterparts, eCOAs.
-
How Risk-Aware Are You? Establishing A Foundation For A Holistic RBQM Strategy
10/3/2022
This paper highlights why the industry is moving towards RBQM and how sponsors can build a scalable approach that protects trial participants, upholds study integrity, and increases operational efficiencies.